This is an 8 week observational study to evaluate the feasibility of using remote monitoring technologies in future studies of PD. The study will 2 clinical evaluations (one initial, one final), and an 8-week monitoring period including 4 virtual visits where participants will use a combination of digital devices (Emerald touchless sensor system with associated ankle accelerometer, iPhone, Apple Watch, iPad, Fitbit Aria, FitBit Versa, Withings Blood Pressure Monitor Connect, and/or Withings Sleep Mat) during their daily lives.
Study Type
OBSERVATIONAL
Enrollment
12
Mobile Clinical Research Site
New York, New York, United States
The feasibility of digital and remote monitoring technologies
determined by evaluating: 1. Ease of deployment and initial set-up, utility of technology and user experience as reported by the usability surveys and interview questionnaires (measured by means of Standard Usability Questionnaire score ranges from 10 to 50, higher score indicating a better usability) 2. Total time and percentage of continuous data collection for each stream of data and frequency and distribution of missing data points. 3. Mutual consistency of data from multiple, related data streams 4. Data utility reports 5. Responses from participants with PD and care partners regarding ease of use and comfort of technologies in study 6. Adherence of participants to active tasks and use of the devices
Time frame: 8 weeks
Correlation with standard measures
Correlation of data from the included digital technologies and their relationship to standard measures (correlations with scores from MDS-UPDRS, PDQ-8 and SE-ADL)
Time frame: 8 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.